Skip to the page
Care question book

Keep the questions. Take your time.

A guide for weighing care

Pause before choosing a BPC-157 medical clinic.

Name the problem you want help with. Then ask what is known, who can assess it and what the bill includes.

The answer to keep in view

No US medicine containing BPC-157 had approval in the records checked on September 28, 2026. Those records are held by the FDA (Food and Drug Administration).

The FDA says the human safety data are too thin to tell what harm BPC-157 might cause.

Take the question list
Your
concern

What is
known?

Who will
help?

What is the full bill?

A useful pauseThe offer is one part of the decision. Your concern stays at the centre.

Give the problem a name.

What has been bothering you? What task would you like to do with less trouble? Write a few words about that before opening a treatment menu.

BPC-157 is made in a lab by joining small chemical parts into a short chain.

Proteins are made from these same small parts. A short chain of the parts is called a peptide.

The name of a substance is not an answer to the problem. Ask for an assessment of the concern itself, including options other than the offered treatment.

What do you think is causing this, and what are my care options?

A room visit and a remote visit are ways to have that conversation. Care at a distance, often by video, is called telehealth.

Before settling on treatment, talk through the problem with a licensed health professional, such as a doctor.

Keep the next question small.

There is no need to settle every issue at once. Take the part that is still unclear and ask for a direct answer.